Global  

Companies to seek emergency approval for use of COVID-19 vaccines

Video Credit: WLFI - Published
Companies to seek emergency approval for use of COVID-19 vaccines
A COVID-19 vaccine could make its way to Indiana within the next few months.

Vaccines from pharmaceutical companies pfizer and moderna.

News 18's balint szalavari is live in downtown lafayette.

Balint, what steps are still needed before a vaccine can arrive?

Jeff,within the past two weeks, pfizer and moderna have both shown promising results from trials of the covid-19 vaccines.

The results find both vaccines to bmore than 90 percent effective at preventing the virus.

Kuhn: "the time couldn't come quick enough for a vaccine."

With promising results from recent studies, both pfizer and moderna are seeking approval for emergency use of their vaccines..

According to richard kuhn, director at purdue's institute of inflammation, immunology and infectious disease, this could happen within a few weeks.

Kuhn: "both pfizer, which is submitting now, and moderna, which should submit within the next week or two, is going to be approved in mid to early december."

Once approved, distribution could begin.

Purdue's distinguished professor of virology surseh (sue-resh) mittal (mittel) says this will be a major turning point in fighting the virus.

Mittal: "the number of infection will go substantially down in a few weeks time once the vaccination will start."

Mittal says distribution will likely follow the cdc's three step plan.

Mittal: "health care people will get the first doses, and then all the other first responders, the police, firefighters.

After, high risk and older aged individuals will receive the vaccine.

Last will be the general public.

Josh johansen is a lafayette resident and health care worker.

He believes it's important everyone gets the vaccine once it's available.

Johansen: "not everyone can get the vaccine.

Not everyone will be able to get it and to protect those people, we have to get the vaccine ourselves."

And west lafayette resident mikel berger says having a vaccine available would be a step in the right direction.

Berger: "i don't expect a vaccine or any other measure to, you know, totally prevent the virus or anything like thathat can get back towards more of the way things used to be is a good thing."

Pfizer estimates they will be able to produce 50 million doses by the end of this year.

In 2021, they estimate up to 1.3 billion doses.

Reporting live in lafayette, balint szalavari, news 18.

We're still months away from a coronavirus vaccine




You Might Like

Related news from verified sources

China's Covid-19 vaccine administered to a million people: Official

A Covid-19 vaccine developed by a state-owned Chinese pharmaceutical firm has been administered to...
IndiaTimes - Published

Pfizer and BioNTech climb as 95% vaccine effectiveness tees up application for FDA approval

The companies aim to apply for emergency-use authorization within days. If approved, the vaccine...
Business Insider - Published Also reported by •CBS NewsWorldNews


Pfizer 'Very Close' to Applying for US Emergency Approval, Says CEO

Pfizer is "very close" to applying for an emergency use approval for its Covid-19 vaccine after...
Newsmax - Published


Related videos from verified sources

‘PM Modi extremely knowledgeable on vaccine’: SII CEO Adar Poonawalla [Video]

‘PM Modi extremely knowledgeable on vaccine’: SII CEO Adar Poonawalla

Serum Institute India CEO Adar Poonawalla spoke on Prime Minister Narendra Modi’s visit to vaccine lab in Pune. Poonawalla said that he was amazed by the Prime Minister's knowledge about vaccines and..

Credit: HT Digital Content     Duration: 04:05Published
Vaccine: Frankfurt Airport prepares for logistical challenge of a lifetime [Video]

Vaccine: Frankfurt Airport prepares for logistical challenge of a lifetime

As a string of COVID-19 vaccines near approval, Frankfurt Airport is preparing to transport millions of life-saving doses worldwide.View on euronews

Credit: euronews (in English)     Duration: 01:26Published
COVID-19: Not in writing on how many doses GOI will purchase, says Serum Institute of India [Video]

COVID-19: Not in writing on how many doses GOI will purchase, says Serum Institute of India

Speaking on COVID-19 pandemic vaccine, Chief executive officer (CEO) of Serum Institute of India, Adar Poonawalla on November 28 said as of now, the government of India has not given anything in..

Credit: ANI     Duration: 01:22Published